Raluca Verona

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes”.

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.10.471975

N/A

0DataRank · unranked

0 citations

Shankara Anand, Romanos Sklavenitis‐Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky +22 more

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Nature Communications(2022)10.1038/s41467-022-30694-w

N/A

0DataRank · unranked

33 citations

Shankara Anand, Romanos Sklavenitis‐Pistofidis, Robert Redd, Eileen M. Boyle, Benny Zhitomirsky +22 more

Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti–programmed cell death protein-1 (PD-1) antibody, in human cancer models

Cancer Chemotherapy and Pharmacology(2022)10.1007/s00280-022-04415-5

N/A

0DataRank · unranked

13 citations

Catherine Ferrante, Gordon Powers, Jocelyn Sendecki, Bethany Mattson, Darlene Pizutti +11 more

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.019

N/A

0DataRank · unranked

1 citations

Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie Crews +18 more